Letetresgene Autoleucel
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Letetresgene Autoleucel, covering 2021-09-05 to 2022-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma [Phase 2]